TScan Therapeutics Announces Upcoming Presentations at the 38th Society for Immunotherapy of Cancer Annual Meeting
WALTHAM, Mass., Sept. 27, 2023 (GLOBE NEWSWIRE) — TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage…
WALTHAM, Mass., Sept. 27, 2023 (GLOBE NEWSWIRE) — TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage…
Funding underscores shift toward open banking and the demand for seamless core integration and innovation…
TORONTO and ABU DHABI, United Arab Emirates, Sept. 27, 2023 (GLOBE NEWSWIRE) — Basetwo, a…
Experienced Epiq AI and Data Management Technologists Deliver Solutions Leveraging the Epiq Service Cloud NEW YORK,…
Toronto, Ontario–(Newsfile Corp. – September 27, 2023) – Two Hands Corporation. (CSE: TWOH) (“Two Hands”…
Toronto, Ontario–(Newsfile Corp. – September 27, 2023) – Justera Health Ltd. (CSE: VTAL) (OTC Pink: SCRSF) (formerly…
Toronto, Ontario–(Newsfile Corp. – September 27, 2023) – SATO Technologies Corp. (TSXV: SATO) (OTCQB: CCPUF)…
MUMBAI, INDIA, Sept 27, 2023 – (ACN Newswire) – StrategINK Solutions Private Limited successfully concluded…
SINGAPORE, Sept 27, 2023 – (ACN Newswire) – PT Bank Tabungan Negara (Persero) Tbk (Bank…
Hugging Face, the leader in open source AI, will offer optimized Generative AI models to…
Building the AI railroad tracks of the future so inference tasks can move seamlessly across…
Cloudflare joins MLflow as an active contributor to bridge the gap between model training and…
NEW YORK–(BUSINESS WIRE)–Flatiron Health is presenting multiple sessions at HMP Global’s Clinical Pathways Congress +…
The newly launched customizable Cybersecurity Performance Boards empower security leaders to manage their own metrics…
MANNHEIM, Germany, Sept. 27, 2023 (GLOBE NEWSWIRE) — Affimed N.V. (Nasdaq: AFMD) (“Affimed”, or the…
MANNHEIM, Germany, Sept. 27, 2023 (GLOBE NEWSWIRE) — Affimed N.V. (Nasdaq: AFMD) (“Affimed”, or the…
BOSTON, Sept. 27, 2023 (GLOBE NEWSWIRE) — Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical…
– Four abstracts highlight Gene Circuit platforms that enhance the scope, precision, effectiveness, and controllability…
BOSTON, Sept. 27, 2023 (GLOBE NEWSWIRE) — Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical…
– Four abstracts highlight Gene Circuit platforms that enhance the scope, precision, effectiveness, and controllability…